Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
Hu-Lowe, D. D., Zou, H. Y., Grazzini, M. L., Hallin, M. E., Wickman, G. R., Amundson, K., Chen, J. H., Rewolinski, D. A., Yamazaki, S., Wu, E. Y., McTigue, M. A., Murray, B. W., Kania, R. S., O'ConnorVolume:
14
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-08-0652
Date:
November, 2008
File:
PDF, 580 KB
english, 2008
File converter
More search results
More benefits 
